Northwest Biotherapeutics (NWBO) Other Working Capital Changes (2019 - 2021)
Northwest Biotherapeutics' (NWBO) quarterly Other Working Capital Changes came in at -$140000.0 in Q1 2026, down 636.84% year-on-year from $26078.4 in Q1 2025, and down 325.81% quarter-over-quarter from $62000.0 in Q4 2025.
Northwest Biotherapeutics (NWBO) Other Working Capital Changes (2019 - 2021) Analysis & Trends
Northwest Biotherapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$140000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 636.84% year-over-year to -$140000.0 in Q1 2026; TTM through Mar 2026 was -$28000.0, a 1500.0% decrease from a year earlier, with the FY2025 full-year figure at $93000.0, up 45.31% from the prior year.
- Other Working Capital Changes declined to -$140000.0 in Q1 2026 per NWBO's latest filing, from $62000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $320000.0 in Q4 2019 and bottomed at -$74000.0 in Q3 2019.
- The 3-year median for Other Working Capital Changes is $58500.0 (2020), against an average of $55800.0.
- Across the five-year window, Other Working Capital Changes jumped 275.0% in 2022 and plunged 636.84% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $37000.0 in 2022, then soared by 237.84% to $125000.0 in 2023, then sank by 133.6% to -$42000.0 in 2024, then surged by 247.62% to $62000.0 in 2025, then tumbled by 325.81% to -$140000.0 in 2026.
- Per Business Quant, the three latest NWBO Other Working Capital Changes figures stand at -$140000.0 (Q1 2026), $62000.0 (Q4 2025), and -$8000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -42,000.00 |
| Jun 30, 2021 | -42,000.00 |
| Jun 30, 2021 | -42,000.00 |
| Mar 31, 2021 | 61,000.00 |
| Mar 31, 2021 | 61,000.00 |
| Mar 31, 2021 | 61,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Sep 30, 2020 | 58,000.00 |
| Sep 30, 2020 | 58,000.00 |
| Sep 30, 2020 | 58,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Dec 31, 2019 | 320,000.00 |
| Dec 31, 2019 | 320,000.00 |